Clinical Trial Summary

---

Phase

N/A

---

Funding Agency/Sponsor

Institutional

---

Disease

Prostate, Bladder, and Kidney Cancers

---

Enrollment Eligibility

Inclusion Criteria:
- Biopsy-proven urothelial cancer being considered for RARC.
- Clinical stage T1-T4, N0-1, M0 or refractory carcinoma in situ.
- Subject must be already scheduled to have a RARC at the discretion of the surgeon and
with the patient's agreement.
Exclusion Criteria:
- Inability to give informed consent
- Prior major abdominal and pelvic open surgical procedures that would preclude a safe
robotic approach, as determined by the treating surgeon.
- At the discretion of the treating surgeon, any pre-existing condition such as severe
chronic obstructive pulmonary disease that precludes a safe initiation or maintenance
of pneumoperitoneum over a prolonged period of time and during surgery.
- Age <18 or >99 years.

---